DNA X, Inc. SONM
$2.99
-$0.03-0.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 16.21M | 11.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 16.21M | 11.19M |
| Cost of Revenue | -- | -- | -- | 14.40M | -- |
| Gross Profit | -- | -- | -- | 1.82M | -- |
| SG&A Expenses | 1.28M | 3.62M | -2.55M | 5.62M | 1.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.28M | 3.62M | -17.13M | 20.19M | 1.47M |
| Operating Income | -1.28M | -3.62M | 915.00K | -3.98M | -1.47M |
| Income Before Tax | -1.24M | -3.93M | -471.00K | -4.66M | -1.86M |
| Income Tax Expenses | -- | -- | -- | 90.00K | -- |
| Earnings from Continuing Operations | -1.24M | -3.93M | -381.00K | -4.75M | -1.86M |
| Earnings from Discontinued Operations | -9.00K | 10.27M | -8.51M | -- | -5.62M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.25M | 6.34M | -8.89M | -4.75M | -7.48M |
| EBIT | -1.28M | -3.62M | 915.00K | -3.98M | -1.47M |
| EBITDA | -1.21M | -2.54M | 2.41M | -3.03M | -674.00K |
| EPS Basic | -0.92 | 5.01 | -9.38 | -4.83 | -14.15 |
| Normalized Basic EPS | -0.66 | -1.94 | 1.41 | -2.96 | -2.20 |
| EPS Diluted | -0.92 | 5.01 | -9.37 | -4.83 | -14.15 |
| Normalized Diluted EPS | -0.66 | -1.94 | 1.41 | -2.96 | -2.20 |
| Average Basic Shares Outstanding | 1.35M | 1.27M | 722.70K | 984.90K | 528.40K |
| Average Diluted Shares Outstanding | 1.35M | 1.27M | 722.70K | 984.90K | 528.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |